Table 3.
Characteristics of patients in the pCR and non-pCR groups after treatment.
pCR (n=15), n (%) | Non-pCR (n=38), n (%) | |
---|---|---|
ypTNM stage | ||
I | NA | 12 (31.6%) |
II | NA | 14 (36.8%) |
III | NA | 12 (31.6%) |
ypT status | ||
T0 | NA | 0 |
T1 | NA | 5 (13.1%) |
T2 | NA | 13 (34.2%) |
T3 | NA | 18 (47.4%) |
T4 | NA | 2 (5.3%) |
ypN status | ||
N0 | NA | 26 (68.4%) |
N1 | NA | 10 (26.3%) |
N2 | NA | 2 (5.3%) |